CONSIDERATIONS TO KNOW ABOUT DIAZEPAM 2MG PIL

Lonafarnib may enhance the AUC and peak focus of CYP2C19 substrates. If coadministration unavoidable, monitor for adverse reactions and lessen the CYP2C19 substrate dose in accordance with its approved products labeling.withdrawal reactions, which include seizures, that may be everyday living-threatening; use gradual taper when discontinuing therap